Technical Analysis for CXRXF - ADVANZ PHARMA Corp.

Grade Last Price % Change Price Change
grade F 3.45 -0.29% -0.0100
CXRXF closed down 0.29 percent on Wednesday, June 3, 2020, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up
Historical CXRXF trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
NR7-2 Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Bollinger Band Squeeze Range Contraction -0.29%
Narrow Range Bar Range Contraction -0.29%
NR7 Range Contraction -0.29%
Weak + Overbought Other -0.29%
Inside Day Range Contraction -0.29%
Older signals for CXRXF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


ADVANZ PHARMA Corp., a specialty pharmaceutical company, through its subsidiaries, owns or licenses a portfolio of branded and generic prescription products. The company operates through two segments, Concordia International and Concordia North America. The Concordia International segment owns or licenses a portfolio of branded and generic prescription products to wholesalers, hospitals, and pharmacies. This segment's products include Macrobid/Macrodantin to treat bladder infections, such as cystitis and urinary tract infections; Tetroxin drug for severe hypothyroid states; Eltroxin, levothyroxine sodium that treats patients with an underactive thyroid gland; and Fucithalmic, a topical gel treatment for patients suffering with a bacterial infection of the surface lining of the front of the eye. The Concordia North America segment provides Donnatalm, which is used as adjunctive therapy for irritable bowel syndrome; Zonegran, an anti-seizure drug indicated for adjunctive therapy in the treatment of partial seizures in adults with epilepsy; and Plaquenil and Plaquenil AG to treat rheumatoid arthritis and manage the complications of lupus, as well as suppress acute attacks from certain strains of malaria. This segment also offers photodynamic therapy with Photofrin for the treatment of certain forms of cancer that combines a photosensitizing agent with a specific type of laser that emits an exact wavelength of light and power to target cancer cells. The company sells its products through direct sales and local partnerships. The company was formerly known as Concordia International Corp. and changed its name to ADVANZ PHARMA Corp. in November 2018. ADVANZ PHARMA Corp. is headquartered in Mississauga, Canada.
Medicine Health RTT Cancer Pharmaceutical Industry Clinical Medicine Pharmaceutical Laser Cancer Treatments Arthritis Epilepsy Laser Medicine Light Therapy Malaria Urinary Tract Infections Photodynamic Therapy Adjunctive Therapy Cystitis Irritable Bowel Syndrome

Is CXRXF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 20.89
52 Week Low 2.5
Average Volume 14,418
200-Day Moving Average 8.7519
50-Day Moving Average 3.6713
20-Day Moving Average 3.3465
10-Day Moving Average 3.3820
Average True Range 0.3006
ADX 10.11
+DI 23.4785
-DI 25.3963
Chandelier Exit (Long, 3 ATRs ) 2.6982
Chandelier Exit (Short, 3 ATRs ) 3.7818
Upper Bollinger Band 3.5808
Lower Bollinger Band 3.1122
Percent B (%b) 0.72
BandWidth 14.0027
MACD Line -0.0761
MACD Signal Line -0.1367
MACD Histogram 0.0606
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.4650
Resistance 3 (R3) 3.4667 3.4633 3.4625
Resistance 2 (R2) 3.4633 3.4595 3.4625 3.4617
Resistance 1 (R1) 3.4567 3.4572 3.4550 3.4550 3.4608
Pivot Point 3.4533 3.4533 3.4525 3.4525 3.4533
Support 1 (S1) 3.4467 3.4495 3.4450 3.4450 3.4392
Support 2 (S2) 3.4433 3.4472 3.4425 3.4383
Support 3 (S3) 3.4367 3.4433 3.4375
Support 4 (S4) 3.4350